Status:
UNKNOWN
SpotLight-19 Research & Development Study
Lead Sponsor:
Ottawa Hospital Research Institute
Collaborating Sponsors:
ISBRG Corp
Conditions:
Screening
Eligibility:
All Genders
3+ years
Phase:
NA
Brief Summary
In this study, we will use the SpotLight-19 device in patients presenting to a coronavirus disease (COVID-19) Assessment Centre for polymerase chain reaction (PCR) testing. Consenting patients will un...
Detailed Description
Implementation of rapid, accessible, and accurate COVID-19 testing is a cornerstone of public health efforts to contain and respond to the spreading virus. To respond to this need, ISBRG Corp is apply...
Eligibility Criteria
Inclusion
- Qualifies for COVID-19 testing as per Assessment Site protocol; or
- Is capable of cooperating with testing
- Is clinically stable such that the testing protocol may be completed safely
Exclusion
- Extreme fingertip scarring or other physical condition that prevents use of the device
Key Trial Info
Start Date :
December 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2022
Estimated Enrollment :
12500 Patients enrolled
Trial Details
Trial ID
NCT05198869
Start Date
December 29 2021
End Date
July 31 2022
Last Update
January 20 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
COVID-19 CHEO Assessment Centre
Ottawa, Ontario, Canada, K1S 5T1
2
COVID-19 Assessment Centre for Adults
Ottawa, Ontario, Canada, K1S5T1